$0.1979
0.1449[273.40%]
At close: Apr 26
EOM Pharma Hldgs
(OTCPK:IMUC)Latest News for EOM Pharma Hldgs Stock (OTC:IMUC)
EOM Pharma Hldgs Stock (OTC: IMUC)
Categories: All
Wednesday, October 23, 2019
Wednesday, October 17, 2018
- ImmunoCellular Shares Resume TradeBenzinga Newsdesk - Oct 17, 2018, 9:32AM
- ImmunoCellular Announces Receipt Of Notice Of Noncompliance With The NYSE American Continued Listing Standards; Trading Of Shares Has Been Suspended And Exchange Plans To Commence Delisting ProceedingsBenzinga Newsdesk - Oct 17, 2018, 6:05AM
Tuesday, October 16, 2018
- ImmunoCellular Therapeutics Shares To Suspend NYSE Trading Immediately And Commence Delisting ProceedingsBenzinga Newsdesk - Oct 16, 2018, 1:58PM
- ImmunoCellular Therapeutics Shares Halted, News PendingBenzinga Newsdesk - Oct 16, 2018, 12:28PM
- The Daily Biotech Pulse: Enzo's Q4 Loss, Sanofi's Positive Trial Results, ImmunoCellular To DelistShanthi Rexaline - Oct 16, 2018, 8:52AM
- ImmunoCellular Therapeutics shares are trading lower after the company announced it would delist the stock.Benzinga Newsdesk - Oct 16, 2018, 8:04AM
Monday, October 15, 2018
Monday, August 13, 2018
Monday, May 14, 2018
Thursday, April 12, 2018
- Penny Stock ImmunoCellular Therapeutics Shares Up 20.3% After Co. Reported Milestone In Stem-to-T-Cell Immuno-Oncology ProgramBenzinga - Apr 12, 2018, 11:13AM
- ImmunoCellular Reports Successful Transfer Of Selected T-Cell Receptor Stem-To-T-Cell Approach, A Key Next Step To Begin Preclinical TestingBenzinga - Apr 12, 2018, 6:11AM
Monday, March 26, 2018
Tuesday, March 13, 2018
Thursday, February 22, 2018
Tuesday, February 13, 2018
Thursday, December 14, 2017
Wednesday, December 13, 2017
Tuesday, November 21, 2017
Wednesday, September 13, 2017
Wednesday, August 23, 2017
- UPDATE: ImmunoCellular Says 'Near-Term Milestones Anticipated in Stem-to-T-Cell Research Program'Benzinga - Aug 23, 2017, 4:09PM
- UPDATE: ImmunoCellular Highlights 'Restructuring Underway Designed to Achieve Cost Savings and Extend Operating Runway'Benzinga - Aug 23, 2017, 4:09PM
- ImmunoCellular Therapeutics Offers Update On R&D ProgramsBenzinga - Aug 23, 2017, 4:09PM